Guiying Wang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Pluripotent Stem Cells Research
- Histone Deacetylase Inhibitors Research
- CRISPR and Genetic Engineering
- Cancer-related gene regulation
Papers in
- Oncology 25
- Colorectal Cancer Surgical Treatments 8
-
- Pluripotent Stem Cells Research 12
- CRISPR and Genetic Engineering 11
- Epigenetics and DNA Methylation 10
- Histone Deacetylase Inhibitors Research 7
- RNA Research and Splicing 5
- Co-authors
- Jiuhong Kang (21 shared papers)Xudong Guo (11 shared papers)Songcheng Zhu (10 shared papers)Dan Ye (7 shared papers)Ye Leng (5 shared papers)Wenwen Jia (7 shared papers)Dandan Yang (5 shared papers)Houqi Liu (3 shared papers)
- Journals
- Frontiers in Oncology (5 papers)Oncotarget (4 papers)PLoS ONE (3 papers)Aging (2 papers)Medicine (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Guiying Wang
97 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 126
- Cancer Research 464
- Molecular Biology 1.1k
- Oncology 299
- Geriatrics and Gerontology 33
- Internal Medicine 16
Countries citing papers authored by Guiying Wang
This map shows the geographic impact of Guiying Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiying Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiying Wang more than expected).
Fields of papers citing papers by Guiying Wang
This network shows the impact of papers produced by Guiying Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiying Wang. The network helps show where Guiying Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiying Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 228 | |
| 2 | 2013 | 149 | |
| 3 | 2013 | 126 | |
| 4 | 2012 | 83 | |
| 5 | 2012 | 76 | |
| 6 | 2018 | 73 | |
| 7 | 2013 | 54 | |
| 8 | 2016 | 51 | |
| 9 | 2018 | 50 | |
| 10 | 2018 | 47 | |
| 11 | 2011 | 39 | |
| 12 | 2015 | 34 | |
| 13 | 2013 | 32 | |
| 14 | 2016 | 31 | |
| 15 | 2008 | 30 | |
| 16 | 2014 | 30 | |
| 17 | 2021 | 30 | |
| 18 | 2017 | 28 | |
| 19 | 2017 | 28 | |
| 20 | 2021 | 26 |
About Guiying Wang
Guiying Wang is a scholar working on Oncology, Molecular Biology, Biophysics, Cancer Research and Surgery, having authored 105 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (12 papers), CRISPR and Genetic Engineering (11 papers), Epigenetics and DNA Methylation (10 papers), Colorectal Cancer Surgical Treatments (8 papers), Histone Deacetylase Inhibitors Research (7 papers), MicroRNA in disease regulation (6 papers), Advanced Fluorescence Microscopy Techniques (5 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Cancer Research (464 citations), Molecular Biology (1.1k citations), Oncology (299 citations), Geriatrics and Gerontology (33 citations) and Internal Medicine (16 citations). Guiying Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jiuhong Kang, Xudong Guo, Songcheng Zhu, Dan Ye, Ye Leng, Wenwen Jia, Dandan Yang, Houqi Liu, Chenqi Lu and Minjuan Wu. Their work appears in journals such as Frontiers in Oncology, Oncotarget, PLoS ONE, Aging and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.